The 4 Hematology Conditions Every FNP Student Must Master Before Board Day

Hematology · 4 min read · October 31, 2026

Demystifying Microcytic Anemias: Iron Deficiency vs. Thalassemia

Anemia is a staple topic on both the AANP and ANCC certification exams, and microcytic anemias (MCV less than 80 fL) show up constantly in clinical vignette questions. The two heavy hitters you must differentiate are Iron Deficiency Anemia (IDA) and Thalassemia Trait.

When evaluating a low MCV, your first step is checking the Red Cell Distribution Width (RDW). In iron deficiency, the RDW is elevated because the bone marrow releases red blood cells of varying sizes as iron stores deplete. Conversely, in thalassemia trait, the RDW is typically normal because the microcytosis is genetic and uniform.

Iron Deficiency Anemia: Expect low ferritin (the best indicator of body iron stores), low serum iron, high Total Iron-Binding Capacity (TIBC), and high RDW. Patients may present with fatigue, pica, koilonychia (spoon nails), or angular cheilitis.
Thalassemia Trait: Expect normal or high ferritin, normal serum iron, normal TIBC, and normal RDW. Often discovered incidentally on a routine Complete Blood Count (CBC) showing disproportionately severe microcytosis given the modest degree of anemia.

Board Pearl: If a patient has a microcytic anemia that does not respond to a therapeutic trial of oral iron, think thalassemia trait or anemia of chronic disease before assuming medication non-adherence.

Macrocytic Anemias: B12, Folate, and Neurological Red Flags

When the MCV is elevated (greater than 100 fL), your differential shifts to macrocytic anemias. The board exam loves testing your ability to distinguish between Vitamin B12 (cobalamin) deficiency and Folate deficiency.

Both conditions present with fatigue and macrocytic red cells, but only Vitamin B12 deficiency causes neurological symptoms. Think of Paresthesias, unsteady gait, memory loss, and peripheral neuropathy. This occurs because B12 is essential for myelin synthesis.

Vitamin B12 Deficiency: Can be caused by pernicious anemia (autoimmune destruction of parietal cells leading to a lack of intrinsic factor), vegan diets, or ileal disease/resection. Check a methylmalonic acid (MMA) and homocysteine level—both will be elevated in B12 deficiency.
Folate Deficiency: Caused by poor dietary intake, alcoholism, or malabsorption. Folate deficiency presents with megaloblastic anemia and elevated homocysteine, but normal MMA levels and no neurological deficits.

Board Pearl: Never treat a macrocytic anemia with empiric folic acid alone until you have ruled out a B12 deficiency. Administering folate to a B12-deficient patient can correct the hematologic abnormalities while allowing irreversible neurological damage to progress.

Idiopathic Thrombocytopenia Purpura (ITP): Diagnosis of Exclusion

Bleeding and clotting disorders frequently appear on FNP boards. Idiopathic Thrombocytopenia Purpura (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia (platelet count typically less than 100,000/mcL) caused by autoantibodies directed against platelet surface antigens.

Often triggered by a preceding viral infection in children or presenting insidiously in adults, ITP is a diagnosis of exclusion. Patients may present with petechiae, purpura, easy bruising, or epistaxis, but physical examination should otherwise be normal—specifically, no splenomegaly. If the spleen is enlarged, you must look for another cause, such as portal hypertension, leukemia, or lymphoma.

Diagnostic Evaluation: CBC shows isolated low platelets with normal white blood cells and hemoglobin. Peripheral smear confirms thrombocytopenia with normal-appearing large platelets. Bone marrow biopsy is generally reserved for adults over 60 or those unresponsive to first-line therapies.
Management: Observation for mild cases with counts above 30,000/mcL without bleeding. First-line medical therapy for active bleeding or significantly depressed counts includes corticosteroids, IVIG, or anti-D immunoglobulin.

Board Pearl: On board exams, isolated thrombocytopenia following a viral illness in an otherwise healthy child points straight to ITP. Do not pick bone marrow biopsy as the initial diagnostic step.

Spotting the Red Flags: Leukemias and Malignancies

Primary care providers are often the first to spot hematologic malignancies on routine labs. You must recognize the core presentations of Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Chronic Myelogenous Leukemia (CML).

Acute Leukemias (ALL, AML): Rapid onset of fatigue, fever, infection (due to neutropenia), bleeding (due to thrombocytopenia), and bone pain. Look for blasts on the peripheral blood smear. ALL is the most common cancer in children, while AML is more common in older adults.
Chronic Leukemias (CLL, CML): Often asymptomatic and discovered incidentally on routine CBCs. CLL is characterized by isolated absolute lymphocytopenia with smudge cells on the smear, primarily affecting older adults. CML features a massive leukocytosis with a left shift and is classically associated with the Philadelphia chromosome (BCR-ABL gene fusion).

Board Pearl: Smudge cells on a peripheral blood smear in an asymptomatic older adult with profound lymphocytosis are a classic board hallmark for Chronic Lymphocytic Leukemia (CLL).

You have got this! Hematology can feel intimidating with all its overlapping pathways and lab values, but by breaking down the data step-by-step, you are building the exact clinical intuition you need to pass your board exams. Head over to The FNP Review to practice more high-yield questions and lock in your success.